Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
5(63%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Terminated(1)

Detailed Status

Recruiting4
Active, not recruiting1
Completed1
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

recruiting450%
active_not_recruiting113%
completed113%
terminated113%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8